Biosensors Journal is one among the best scholarly journals on nanobiotechnology. All published articles are assigned to Digital Object Identifier (DOI) CrossRef and are freely accessed using Google scholar. Scholars from all relevant academic fields are invited to submit high-quality manuscripts that describe the latest, state-of-the-art research results or innovations on nanobiotechnology.
Nanobiotechnology, sometimes referred to as nanobiology or bionanotechnology, is best described as helping modern medicine progress from treating symptoms to generating cures and regenerating biological tissues. Using nanobiotechnology techniques, it has been demonstrated in animal studies that a uterus can be grown outside the body and then placed in the body in order to produce a baby. Stem cell treatments have been used to fix diseases that are found in the human heart and are in clinical trials. Artificial proteins might also become available to manufacture without the need for harsh chemicals and expensive machines through nanobiotechnology.
OMICS Group is built upon the principles of open access and is determined to provide free and unrestricted access of research articles to scientists around the world for the advancement of science and technology. Submitted articles in the Biosensors Journal avail open accessing. OMICS special features include 21 Day rapid review process and an eminent team of 50,000+ editorial board members and 50,000+ Reviewer team. Open Access initiative helps in unlocking the traditional methods of subscription articles and releasing information to tertiary level readers, who normally would not have access to first hand research studies.
Last date updated on June, 2014